Your browser doesn't support javascript.
loading
Human thymopoiesis produces polyspecific CD8+ α/ß T cells responding to multiple viral antigens.
Quiniou, Valentin; Barennes, Pierre; Mhanna, Vanessa; Stys, Paul; Vantomme, Helene; Zhou, Zhicheng; Martina, Federica; Coatnoan, Nicolas; Barbie, Michele; Pham, Hang-Phuong; Clémenceau, Béatrice; Vie, Henri; Shugay, Mikhail; Six, Adrien; Brandao, Barbara; Mallone, Roberto; Mariotti-Ferrandiz, Encarnita; Klatzmann, David.
Afiliación
  • Quiniou V; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Barennes P; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Mhanna V; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Stys P; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Vantomme H; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Zhou Z; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Martina F; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Coatnoan N; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
  • Barbie M; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Pham HP; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
  • Clémenceau B; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Vie H; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Shugay M; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.
  • Six A; ILTOO pharma, Statistical department, Paris, France.
  • Brandao B; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
  • Mallone R; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
  • Mariotti-Ferrandiz E; Center of Life Sciences, Skoltech, Moscow, Russian Federation.
  • Klatzmann D; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy, Paris, France.
Elife ; 122023 03 30.
Article en En | MEDLINE | ID: mdl-36995951
ABSTRACT
T-cell receptors (TCRs) are formed by stochastic gene rearrangements, theoretically generating >1019 sequences. They are selected during thymopoiesis, which releases a repertoire of about 108 unique TCRs per individual. How evolution shaped a process that produces TCRs that can effectively handle a countless and evolving set of infectious agents is a central question of immunology. The paradigm is that a diverse enough repertoire of TCRs should always provide a proper, though rare, specificity for any given need. Expansion of such rare T cells would provide enough fighters for an effective immune response and enough antigen-experienced cells for memory. We show here that human thymopoiesis releases a large population of clustered CD8+ T cells harboring α/ß paired TCRs that (i) have high generation probabilities and (ii) a preferential usage of some V and J genes, (iii) which CDR3 are shared between individuals, and (iv) can each bind and be activated by multiple unrelated viral peptides, notably from EBV, CMV, and influenza. These polyspecific T cells may represent a first line of defense that is mobilized in response to infections before a more specific response subsequently ensures viral elimination. Our results support an evolutionary selection of polyspecific α/ß TCRs for broad antiviral responses and heterologous immunity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Antígenos Virales Límite: Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Antígenos Virales Límite: Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Francia